Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market - Forecast to 2024

1 EXECUTIVE SUMMARY 19

2 INTRODUCTION 24

• 2.1 KEY TAKEAWAYS 24
• 2.2 SCOPE OF THE REPORT 25
• 2.3 REPORT DESCRIPTION 25
• 2.4 MARKETS COVERED 27
• 2.5 STAKEHOLDERS 27
• 2.6 RESEARCH METHODOLOGY 28
  • 2.6.1 MARKET SIZE ESTIMATION 29
  • 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 32
  • 2.6.3 SECONDARY SOURCES 33
  • 2.6.4 PRIMARY SOURCES 34
  • 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 34
  • 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 35
  • 2.6.7 ASSUMPTIONS 35

3 MARKET ANALYSIS 38

• 3.1 INTRODUCTION 38
• 3.2 MARKET SEGMENTATION 39
• 3.3 FACTORS INFLUENCING MARKET 41
  • 3.3.1 DRIVERS AND OPPORTUNITIES 42
    • 3.3.1.1 Increase in number of patients with arrhythmia 42
    • 3.3.1.2 Emerging technologies in electrophysiology 42
    • 3.3.1.3 Rising geriatric population prone to chronic disorders 43
    • 3.3.1.4 Increase in research and development activities 43
    • 3.3.1.5 Increase in minimally invasive surgery for atrial fibrillation 44
  • 3.3.2 RESTRAINTS AND THREATS 45
    • 3.3.2.1 High cost of the devices 45
    • 3.3.2.2 Exposure to radiation 45
    • 3.3.2.3 Inaccuracy of the imaging systems due to body movements 46
    • 3.3.2.4 Stringent regulatory guidelines 46
    • 3.3.2.5 Lack of skilled and trained professionals 47
    • 3.3.2.6 Availability of alternative products 48
• 3.4 REGULATORY AFFAIRS 49
  • 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 49
    • 3.4.1.1 ISO 9001: 2015 quality management system 49
    • 3.4.1.2 ISO 13485 medical devices 49
    • 3.4.1.3 ISO 10993 biological evaluation of medical devices 50
  • 3.4.2 U.S. 50
  • 3.4.3 CANADA 51
  • 3.4.4 EUROPE 52
  • 3.4.5 JAPAN 52
  • 3.4.6 CHINA 53
  • 3.4.7 INDIA 53
• 3.5 REIMBURSEMENT SCENARIO 54
  • 3.5.1 REIMBURSEMENT TABLE 55
• 3.6 PATENT TRENDS 56
• 3.7 TECHNOLOGICAL ADVANCEMENTS 59
  • 3.7.1 INTRODUCTION 59
  • 3.7.2 RHYTHMIA HDX MAPPING SYSTEM 59
  • 3.7.3 ENSITE PRESICION MAPPING SYSTEM 59
  • 3.7.4 ACQMAP HIGH RESOLUTION IMAGING AND MAPPING SYSTEM 60
• 3.8 PORTER’S FIVE FORCE ANALYSIS 61
  • 3.8.1 THREAT OF NEW ENTRANTS 62
  • 3.8.2 THREAT OF SUBSTITUTES 62
  • 3.8.3 BARGAINING POWER OF SUPPLIERS 63
  • 3.8.4 BARGAINING POWER OF BUYERS 63
  • 3.8.5 COMPETITIVE RIVALRY 64
• 3.9 SUPPLY CHAIN ANALYSIS 65
• 3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 69
  • 3.10.1 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS 69
  • 3.10.2 MARKET SHARE ANALYSIS OF MAPPING AND NAVIGATION SYSTEMS BY MAJOR PLAYERS 72
  • 3.10.3 MARKET SHARE ANALYSIS OF RECORDING SYSTEMS BY MAJOR PLAYERS 74
• 3.11 MARKET PENETRATION OF CARDIAC EP MAPPING CATHETER AND NAVIGATION CATHETER PROCEDURES IN GLOBAL CARDIAC ABLATION PROCEDURES AND GLOBAL CARDIAC SURGERIES 76
• 3.12 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES NUMBER OF UNITS BY REGION 78
  • 3.12.1 MAPPING SYSTEMS AND NAVIGATION SYSTEMS NUMBER OF UNITS BY REGION 79
  • 3.12.2 RECORDING SYSTEMS NUMBER OF UNITS BY REGION 80
• 3.13 MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL PROCEDURAL VOLUME BY REGION 81
• 3.14 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES COMPANY COMPARISON TABLE BY PRODUCTS 82

4 CARDIAC ELECTROPHYSIOLOGY (EP) MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET, BY PRODUCT 87

• 4.1 INTRODUCTION 87
• 4.2 MAPPING SYSTEMS AND NAVIGATION SYSTEMS 91
  • 4.2.1 CONTACT MAPPING SYSTEMS 96
  • 4.2.2 NON CONTACT MAPPING SYSTEMS 99
• 4.3 MAPPING CATHETERS AND NAVIGATION CATHETERS 102
• 4.4 RECORDING SYSTEMS 105
• 4.5 ACCESSORIES 108

5 CARDIAC ELECTROPHYSIOLOGY (EP) MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET, BY END-USERS 111

• 5.1 INTRODUCTION 111
• 5.2 HOSPITALS 114
• 5.3 CARDIAC CENTERS/AMBULATORY SURGICAL CENTERS 117
• 5.4 OTHER END-USER 120

6 REGIONAL ANALYSIS 123

• 6.1 INTRODUCTION 123
• 6.2 NORTH AMERICA 126
  • 6.2.1 U.S. 134
  • 6.2.2 OTHERS 137
• 6.3 EUROPE 139
  • 6.3.1 GERMANY 146
  • 6.3.2 U.K. 148
  • 6.3.3 FRANCE 150
  • 6.3.4 OTHERS 152
• 6.4 APAC 154
  • 6.4.1 JAPAN 161
  • 6.4.2 CHINA 163
  • 6.4.3 INDIA 165
  • 6.4.4 OTHERS 167
• 6.5 ROW 169
  • 6.5.1 BRAZIL 176
  • 6.5.2 REST OF LATAM 178
  • 6.5.3 MIDDLE EAST & OTHERS 180

7 COMPETITIVE LANDSCAPE 182

• 7.1 INTRODUCTION 182
• 7.2 APPROVALS 183
• 7.3 NEW PRODUCT LAUNCH 187
• 7.4 ACQUISITIONS 189
• 7.5 AGREEMENTS 190

8 MAJOR COMPANIES 191

• 8.1 ABBOTT LABORATORIES 191
  • 8.1.1 OVERVIEW 191
  • 8.1.2 FINANCIALS 192
  • 8.1.3 PRODUCT PORTFOLIO 196
  • 8.1.4 KEY DEVELOPMENTS 196
  • 8.1.5 BUSINESS STRATEGY 198
  • 8.1.6 SWOT ANALYSIS 199
• 8.2 ACUTUS MEDICAL 200
  • 8.2.1 OVERVIEW 200
  • 8.2.2 FINANCIALS 200
  • 8.2.3 PRODUCT PORTFOLIO 200
  • 8.2.4 KEY DEVELOPMENTS 201
  • 8.2.5 BUSINESS STRATEGY 202
  • 8.2.6 SWOT ANALYSIS 203
• 8.3 AURIS SURGICAL ROBOTICS (HANSEN MEDICAL) 204
  • 8.3.1 OVERVIEW 204
  • 8.3.2 FINANCIALS 204
  • 8.3.3 PRODUCT PORTFOLIO 205
  • 8.3.4 KEY DEVELOPMENTS 205
  • 8.3.5 BUSINESS STRATEGY 206
  • 8.3.6 SWOT ANALYSIS 207
• 8.4 BOSTON SCIENTIFIC CORPOARTION 208
  • 8.4.1 OVERVIEW 208
  • 8.4.2 FINANCIALS 209
  • 8.4.3 PRODUCT PORTFOLIO 213
  • 8.4.4 KEY DEVELOPMENTS 213
  • 8.4.5 BUSINESS STRATEGY 214
  • 8.4.6 SWOT ANALYSIS 215
• 8.5 GE HEALTHCARE (GENERAL ELECTRIC COMPANY) 216
  • 8.5.1 OVERVIEW 216
  • 8.5.2 FINANCIALS 217
  • 8.5.3 PRODUCT PORTFOLIO 221
  • 8.5.4 KEY DEVELOPMENTS 221
  • 8.5.5 BUSINESS STRATEGY 221
  • 8.5.6 BUSINESS STRATEGY 222
• 8.6 JOHNSON & JOHNSON (BIOSENSE WEBSTER) 223
  • 8.6.1 OVERVIEW 223
  • 8.6.2 FINANCIALS 224
  • 8.6.3 PRODUCT PORTFOLIO 227
  • 8.6.4 KEY DEVELOPMENTS 227
  • 8.6.5 BUSINESS STRATEGY 228
  • 8.6.6 SWOT ANALYSIS 229
• 8.7 MAGNETECS CORPORTION 230
  • 8.7.1 OVERVIEW 230
  • 8.7.2 FINANCIALS 230
  • 8.7.3 PRODUCT PORTFOLIO 230
  • 8.7.4 KEY DEVELOPMENTS 230
  • 8.7.5 BUSINESS STRATEGY 231
  • 8.7.6 SWOT ANALYSIS 232
• 8.8 MEDTRONIC, PLC 233
  • 8.8.1 OVERVIEW 233
  • 8.8.2 FINANCIALS 234
  • 8.8.3 PRODUCT PORTFOLIO 237
  • 8.8.4 KEY DEVELOPMENTS 238
  • 8.8.5 BUSINESS STRATEGY 238
  • 8.8.6 SWOT ANALYSIS 239
• 8.9 MICROPORT SCEINTIFIC CORPORTION 240
  • 8.9.1 OVERVIEW 240
  • 8.9.2 FINANCIALS 241
  • 8.9.3 PRODUCT PORTFOLIO 243
  • 8.9.4 KEY DEVELOPMENTS 244
  • 8.9.5 BUSINESS STRATEGY 244
  • 8.9.6 SWOT ANALYSIS 245
• 8.10 STEREOTAXIS, INC. 246
  • 8.10.1 OVERVIEW 246
  • 8.10.2 FINANCIALS 247
  • 8.10.3 PRODUCT PORTFOLIO 249
  • 8.10.4 KEY DEVELOPMENTS 250
  • 8.10.5 BUSINESS STRATEGY 251